Veristat has agreed to acquire Certara’s regulatory and medical writing [...]

Allucent has appointed new therapeutic strategy leaders across key disease [...]

Aravax has appointed two senior industry figures to its board [...]

Hansa Biopharma’s Biologics License Application (BLA) for imlifidase has been [...]

Lario Therapeutics awarded $2.4M by The Michael J. Fox Foundation [...]

Polaryx Therapeutics, Inc has selected a leading contract research organization [...]

Neupulse, a UK-based neurotherapeutics company, has raised £3 million in [...]

Insilico Medicine and China Medical System Holdings Limited (CMS) have [...]

CellProthera has acquired full rights to the transendocardial catheter originally [...]

Oryzon Genomics has appointed Rolando Gutierrez-Esteinou, as chief medical officer [...]